Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
CompletedOBSERVATIONAL
Enrollment
134
Participants
Timeline
Start Date
July 31, 2015
Primary Completion Date
December 31, 2021
Study Completion Date
June 30, 2022
Conditions
Von Willebrands Disease
Trial Locations (1)
61615
Bleeding and Clotting Disorders Institute, Peoria
All Listed Sponsors
collaborator
Versiti
OTHER
lead
Jonathan Roberts
OTHER
NCT02466789 - Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD) | Biotech Hunter | Biotech Hunter